| • |
Invest in ME have initiated a UK Rituximab Project. This is being progressed
|
| • |
Our advisor is Professor Jonathan Edwards, Emeritus Professor of Connective Tissue Medicine at University College London (UCL)
|
| • |
The clinical trial will be performed when the preliminary research has produced sufficient data to enable the trial to begin.
|
| • |
There is laboratory expertise in B cell immunology under Dr Jo Cambridge.
|
| • |
The research is being set up in collaboration with clinicians with expertise in ME from around London, and in particular Dr Amolak Bansal.
|
| • |
External peer reviewing of a rituximab trial will be arranged by Invest in ME.
|
| • |
Invest in ME already arranged a visit to Bergen by Professor Edwards to meet Dr Fluge and Professor Mella to discuss their clinical trial in detail - thus enhancing cooperation and research.
|
| • |
Invest in ME have agreed to fully fund the preliminary study by UCL which became a pre-cursor to a full clinical trial. This is ongoing.
|
| • |
The preliminary study will aim to confirm the earlier work of Dr Amolak Bansal [1] on B-cells but using a different cohort of ME patients.
Professor Edwards believes this is a useful study in its own right and a pre-requisite for the clinical trial.
|
| • |
The fundraising for this trial is being organised and coordinated by IiME so please contact IiME directly if you or your organisation would like to contribute. Our unique MATRIX crowdfunding scheme will allow multiple funders to easily contribute to the IiME UK trial funding.
|
